Evolent Health Reports Q3 2026 Revenue of $725.37 Million, GAAP EPS Loss of $0. ...
Revenue of $725.4 Million Beats the $724.19 Million Analyst Estimate; Adjusted EPS Also Tops Expectations Related Stocks: EVH ,
Revenue of $725.4 Million Beats the $724.19 Million Analyst Estimate; Adjusted EPS Also Tops Expectations Related Stocks: EVH ,